The financial results for Anteris for the year ended December 31, 2024 are reviewed below. All amounts in $ refer to U.S. dollars. In 2024, Net Sales were $2.7 million relating to sales of our tissue ...

Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed ...

A recent study has highlighted the sex-specific implications of myocardial fibrosis on mortality in patients with severe ...

The webcasts of the TD Cowen and Barclays fireside chats can be accessed by visiting the Investor Center section of the Company’s website at ...

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care ...

A surge protector acts like a gatekeeper. Under normal conditions, it allows electricity to pass through safely to your ...

A second atrial waveform is superimposed at the end of each QRS complex — it is most obvious in leads aVR and V1 (↓ ... lecturer in medicine at Harvard Medical School. Although retired ...

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Anteris Technologies Ltd (AVR). However, you won't necessarily see their names in the company’s ...

The phase II data are promising for patients who are managed with watchful waiting before being offered an intervention.

ASX 200 futures are down 10pts (-0.12%) as of 8:30 am AEDT. In a nutshell: Dow ends lower, S&P 500 and Nasdaq eke out gains Investors get rattled by more tariff threats from President Trump Kerry is ...